San Francisco CEO
January 10-11, 2026
Four Seasons, San Francisco
San Francisco CEO brings together leading biopharma CEOs, heads of R&D, top academic researchers, and life science investors the weekend prior to the JP Morgan Healthcare Conference for off-the-record discussion, held at the Four Seasons San Francisco. Join us for an intimate event with leaders in the industry.
Featured Speakers
Renowned Academics & Researchers
World-class CEOs
Pharma R&D Leaders
Top Strategy Executives
Leading Biotech CEOs
Research & Regulatory Leaders
Blue-chip Investors
Highlights from last year's San Francisco CEO
Watch highlights from San Francisco CEO, including interviews with Teresa Graham (CEO, Roche Pharma), Bill Mezzanotte (Head, R&D, CSL), Levi Garraway (CMO, Roche Genentech), Jay Bradner (EVP, R&D & CSO, Amgen), Steve Hahn (former Commissioner, FDA), Marianne De Backer (CEO, Vir Bio), Jeremy Levin (CEO, Ovid Therapeutics), Mathai Mammen (CEO, Parabilis Medicines), Marc Tessier-Lavigne (CEO, Xaira), Johan Luthman (Head, R&D, Lundbeck), among others.
Venue
San Francisco CEO is hosted in downtown San Francisco immediately prior to the JP Morgan Healthcare Conference.
Four Seasons Hotel San Francisco
757 Market Street
San Francisco, CA
415-633-3000
Agenda
Saturday, January 10, 2026
7:00 am
REGISTRATION & NETWORKING BREAKFAST
7:30 am
LONGWOOD FUND INTRODUCTION
Christoph Westphal, General Partner, Longwood Fund
7:45 am
TRANSLATING SCIENCE INTO MEDICINE
Azad Bonni, Global Head, Pharma Research & Early Development, ad interim, Roche
Bill Dahut, CSO, American Cancer Society
Chris Loose, CEO, Progentos Therapeutics
Moderator: Meg Alexander, CEO, Ovid Therapeutics
8:15 am
BIOPHARMA PIPELINE SOURCING
Brian Safina, CEO, Magnet Biomedicine
Tarek Samad, SVP & Global Head, Research, Lundbeck
Tadaaki Taniguchi, Chief Research & Development Officer, Astellas
Sam Windsor, CEO, Ignota Labs
Moderator: Sekhar Naik, CEO, MResult
8:45 am
THE EVOLVING DEAL-MAKING LANDSCAPE
Rachna Khosla, SVP, BD, Amgen
Stefan König, CEO, Merz
Matthias Müllenbeck, SVP, Head, Global BD & Alliance Management, EMD Serono
David Redfern, President, Corporate Development, GSK
Moderator: Daniel Palmacci, President, Specialized Modalities, Lonza
9:15 am
ADAPTING TO FUNDING ENVIRONMENT CONSTRAINTS
Paris Panayiotopoulos, Senior Managing Director, Blackstone
Ben Liu, CEO, Formation Bio
Eric Murphy, CEO, Sidewinder Therapeutics
Jacob Rubens, Origination Partner, Flagship Pioneering
Moderator: Kara Carter, CEO, Viraccio Therapeutics
9:45 am
NETWORKING BREAK
10:15 am
DEVELOPING AN EFFECTIVE BOARD
Jie D'Elia, CEO, SystImmune
Nenad Grmusa, CEO, DEM BioPharma
Anat Naschitz, CEO, 9vc
Elaine Sun, COO & CFO, Mammoth Bio
Moderator: Shalabh Gupta, CEO, Unicycive
10:45 am
ADVANCES IN CLINICAL TRIALS
Christian Antoni, Chief Development Officer I&I, Pfizer
Judy Chou, CEO, AltruBio
Sandi Dunn, CEO, Phoenix Molecular Designs
Jim Wooldridge, CMO, Immunitas
Moderator: Akhil Rachamadugu, Head, Life Sciences, Americas, ServiceNow
11:15 am
NAVIGATING THE REGULATORY LANDSCAPE
Anissa Kalinowski, CEO, Halo Biosciences
Ed Kaye, CEO, Aurora Therapeutics
Thomas Lonngren, former Director, EMA
Bill Lundberg, CEO, Merus
Moderator: Richard Paulson, CEO, Karyopharm
11:45 am
FIRESIDE CHAT
Hal Barron, CEO, Altos Labs
Lloyd Minor, Dean, Stanford Medicine
Moderator: Seema Kumar, CEO, Cure
12:05 pm
NETWORKING LUNCHEON
1:00 pm
R&D COLLABORATION
Anna Greka, Founder & Chair, Broad L2C Accelerator, Harvard & MIT
Roby Kanichay, Head, Technologies & Externalizations, Global BD & Alliance Management, EMD Serono
Michelle Longmire, CEO, Medable
Michael McCully, President & COO, Syndeio Biosciences
Leif Pedersen, President, Certara
Moderator: Michael Hayden, CEO, Prilenia
1:35 pm
HEALTH DISPARITIES AND ENSURING ACCESS TO INNOVATION
Julian Adams, CEO, Stand Up to Cancer
Sabrina Johnson, CEO, Daré Bioscience
Liz Thompson, EVP, R&D, Acadia
Greg Tietjen, CEO, Revalia Bio
Moderator: Maya Skubatch, Partner, Wilson Sonsini
2:05 pm
POSITIONING FOR COMMERCIAL SUCCESS
Derek Adams, CEO, Stellular Bio
Lori Englebert, CCO, Compass Pathways
Aziz Mottawala, CCO, Tarsus
Tolga Tanguler, CCO, Alnylam
Moderator: Stephen Blaising, Co-Founder & Chairman, Brain Surgery Worldwide
2:35 pm
ACCELERATING DRUG DEVELOPMENT
Lovisa Afzelius, General Partner, Flagship Pioneering
Bruno Gomes, Head, Early Clinical Development, Oncology, Roche
Cindy Perettie, EVP, Head, Kite Pharma
Jonathan Powell, Head, Development, Calico Labs
Moderator: Stef van Grieken, CEO, Cradle
3:05 pm
NETWORKING BREAK
3:35 pm
FIRESIDE CHAT
Carolyn Bertozzi, Nobel laureate; Professor, Stanford University
Jennifer Doudna, Nobel laureate; UC Berkeley
Moderator: Christoph Westphal, General Partner, Longwood Fund
4:00 pm
DEVELOPING GLOBAL PARTNERSHIPS
Juliette Audet, Chief Business and Strategy Officer, NewAmsterdam Pharma
Dan Paterson, CEO, Verastem
Deniz Razon, CBO, Servier
Bruce Rogers, CEO, Dirigent Bio
Moderator: Konstantina Katcheves, SVP, Chief Business & Strategy Officer, Acadia Pharmaceuticals
4:30 pm
INVESTMENT OUTLOOK
Ksenija Pavletic, General Partner & CCO, Jeito Capital
Kinnari Patel, CEO, RTW Institution
Claudine Prowse, Venture Partner, JPM Private Capital
Moderator: Vikas Goyal, Partner, Longwood Fund
5:00 – 6:30 pm
COCKTAIL RECEPTION
Sunday, January 11, 2026
7:00 am
REGISTRATION & NETWORKING BREAKFAST
7:30 am
LONGWOOD FUND INTRODUCTION
Vikas Goyal, Partner, Longwood Fund
7:45 am
DRIVING PRODUCTIVITY IN R&D
Nadim Ahmed, CEO, Cullinan Therapeutics
Maureen Hillenmeyer, CEO Hexagon Bio
Najat Khan, CEO, Recursion
Raj Prasad, CFO, CRISPR Therapeutics
Moderator: Yiannis Kiachopoulos, CEO, Causaly
8:15 am
IMPACT OF COMPANY MINDSET & CULTURE
Will Lewis, CEO, Insmed
Mathai Mammen, CEO, Parabilis Medicines
Trevor Martin, CEO, Mammoth Biosciences
Natalia Misciattelli, CEO, AAVantgarde Bio
Moderator: Smita Pillai, SVP, Talent Development, Inclusion & Innovation Culture, Regeneron
8:45 am
ECOSYSTEM OF EXTERNAL INNOVATION
Ruchira Glaser, EVP & Global Head, CVRM Development, Novartis
Nouhad Husseini, SVP, Head, BD & Corporate Strategy, Regeneron
Marc Tessier-Lavigne, CEO, Xaira
Jingsong Wang, CEO, Harbour BioMed
Moderator: Philippe Lopes-Fernandes, CBO, Ipsen
9:15 am
FIRESIDE CHAT
Sharon Barr, EVP, Head, BioPharmaceuticals R&D, AstraZeneca
Jay Bradner, EVP, R&D, Amgen
Robert Plenge, EVP, Chief Research Officer, Head of Research, BMS
Moderator: Christoph Westphal, General Partner, Longwood Fund
9:35 am
NETWORKING BREAK
10:00 am
CROSSROADS OF SCIENCE & POLICY: SUSTAINING THE ENGINE OF INNOVATION
Robert Califf, former Commissioner, FDA
Julie Gerberding, CEO, Foundation for the NIH; former Director, CDC
Jeremy Levin, Chair, Ovid Therapeutics
Uli Stilz, former Corporate VP, Novo Nordisk
Moderator: Harvey Berger, CEO, Arena BioWorks
10:30 am
PATIENT-CENTRIC DEVELOPMENT
Mike Exton, CEO, Lexicon Pharmaceuticals
Erik Ingelsson, CSO, Wave Life Sciences
Anne Klibanski, CEO, Mass General Brigham
Richard Wilson, SVP, Primary Focus Lead, Genetic Regulation, Astellas
Moderator: Lisa Ricciardi, CEO, Cognition Therapeutics
11:00 am
MANAGING THE RUNWAY
Larry Hamann, CEO, Interdict Bio
Carl Hansen, CEO, AbCellera
Kabir Nath, CEO, Compass Pathways
Brendan Smith, CEO, Weaver
Moderator: Jeb Keiper, Board Director, Cardurion Pharmaceuticals
11:30 am
PIPELINE PRIORITIZATION
Eliav Barr, CMO & Head, Global Clinical Development, Merck
Marianne De Backer, CEO, Vir Bio
Ruxandra Draghia-Akli, EVP, Head, R&D, Novavax
Lara Sullivan, CEO, Pyxis Oncology
Moderator: Pascal Touchon, Operating Partner, Jeito Capital
12:00 pm
NETWORKING LUNCHEON
1:00 pm
THE FUTURE OF HEALTHCARE: INNOVATION, IMPACT AND THE PHARMA PLAYBOOK OF TOMORROW
Teresa Graham, CEO, Roche Pharma
Arianna Huffington, CEO, Thrive Global
Stefan Oelrich, CEO, Bayer Pharma
Moderator: Christoph Westphal, General Partner, Longwood Fund
1:30 pm
IDENTIFYING NEXT-GENERATION THERAPEUTICS
Angela Hwang, CEO, Metaphore Biotechnologies
Daphne Koller, CEO, Insitro
Brent Vaughan, CEO, Eratos Therapeutics
Phil Vickers, CEO, Solu Therapeutics
Moderator: Zhen Su, CEO, Marengo Therapeutics
2:00 pm
ADVANCING LATE-STAGE ASSETS
James Mackay, CEO, Crystalys Therapeutics
Bill Mezzanotte, EVP, R&D, CSL
Lars Petersen, CEO, FUJIFILM Biotechnologies
Matt Winton, Chief Commercial & Business Officer, CervoMed
Moderator: Vikram Karnani, CEO, Collegium Pharmaceuticals
2:30 pm
NETWORKING BREAK
2:50 pm
FIRESIDE CHAT
Levi Garraway, CMO, Roche Genentech
George Yancopoulos, President & CSO, Regeneron
Moderator: Christoph Westphal, General Partner, Longwood Fund
3:10 pm
ENSURING GLOBAL ACCESS
Rahul Ballal, CEO, Mediar Therapeutics
Ivan Cheung, CEO, NextPoint Therapeutics
Ronny Gal, Chief Strategy Officer, Novartis
Tong Zhang, CBO & CFO, VelaVigo
Moderator: Ram Palanki, CCO, REGENXBIO
3:45 pm
ASSESSING INVESTMENT RISK
Ann DeWitt, General Partner, Engine Ventures
Ansbert Gadicke, Managing Partner, MPM BioImpact
Brienne Kugler, SVP, Research & Investments, Royalty Pharma
Bob Nelsen, Managing Director, ARCH Venture Partners
Moderator: Vikas Goyal, Partner, Longwood Fund
Speaking Faculty
